Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Calgary

$68,851.00

Development of a Blood Test for Colorectal Cancer based on Metabolomic Signature**

FY 2018-19

Summary
Colorectal cancer (CRC) is the second leading cause of cancer death in the western world.*Ideally, CRC will be detected early because treatments become progressively more*complicated, toxic and expensive in later disease stages, and the survival is best in early*stage of disease. That is the basis of screening. Currently, the gold standard screening test is*colonoscopy, which is invasive, expensive and difficult to perform on large populations. One*strategy is to enrich the subgroup that requires a colonoscopy by doing a stool test (called a*fecal immunohistochemical test, FIT). The problem is that compliance for stool tests is less*than 40% because testing stool is objectionable and inconvenient. We have developed a*blood test based on the chemical composition of serum. This test is quite sensitive and it has*already been tested on over 600 patients. In this project, in collaboration with Med-Life*Discoveries and Innovate Calgary, as well as a multidisciplinary science team, we will further*refine the test, then create a diagnostic test that can be used in a typical clinical laboratory.*Software will be developed to enhance the capability to analyze test results. Finally, we will*test the new diagnostic test on blood samples collected from close to 3500 individuals who*had screening colonoscopies. At the end, we will have a convenient, clinically applicable test*that will be tested in the future in a larger clinical trial that would inform regulatory agencies*and clinicians on the value of this new test as an alternative screening tool.
Program
Collaborative Health Research Projects
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
523397-2018
Name nom
Bathe, Oliver
Department département
Surgery
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
68851
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Development of a Blood Test for Colorectal Cancer based on Metabolomic Signature**
Keyword
NSERC
Application summary
Colorectal cancer (CRC) is the second leading cause of cancer death in the western world.*Ideally, CRC will be detected early because treatments become progressively more*complicated, toxic and expensive in later disease stages, and the survival is best in early*stage of disease. That is the basis of screening. Currently, the gold standard screening test is*colonoscopy, which is invasive, expensive and difficult to perform on large populations. One*strategy is to enrich the subgroup that requires a colonoscopy by doing a stool test (called a*fecal immunohistochemical test, FIT). The problem is that compliance for stool tests is less*than 40% because testing stool is objectionable and inconvenient. We have developed a*blood test based on the chemical composition of serum. This test is quite sensitive and it has*already been tested on over 600 patients. In this project, in collaboration with Med-Life*Discoveries and Innovate Calgary, as well as a multidisciplinary science team, we will further*refine the test, then create a diagnostic test that can be used in a typical clinical laboratory.*Software will be developed to enhance the capability to analyze test results. Finally, we will*test the new diagnostic test on blood samples collected from close to 3500 individuals who*had screening colonoscopies. At the end, we will have a convenient, clinically applicable test*that will be tested in the future in a larger clinical trial that would inform regulatory agencies*and clinicians on the value of this new test as an alternative screening tool.
University of Calgary - $68,851 Grant (2018-19) | Canada Spends